Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.asterdmhealthcare.com | |
Market Cap | 16,366.55 Cr. | |
Enterprise Value(EV) | 18,110.58 Cr. | 2023-03 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 7.23 | Trailing Twelve Months Ending 2023-06 |
Price-Earning Ratio (PE) | 45.30 | Trailing Twelve Months Ending 2023-06 |
Industry PE | 54.39 | Trailing Twelve Months Ending 2023-06 |
Book Value / Share | 89.59 | Trailing Twelve Months Ending 2023-06 |
Price to Book Value | 3.66 | Calculated using Price: 327.65 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 49.95 Cr. | 499,513,060 Shares |
FaceValue | 10 | |
About Aster DM Healthcare Ltd. | ||
The company operates in multiple segments of the healthcare industry, including hospitals, clinics and retail pharmacies and provide healthcare services to patients across economic segments in several GCC states through its various brands “Aster”, “Medcare” and “Access”. A majority of its hospitals and clinics provide secondary and tertiary healthcare services to patients. In addition to providing core medical, surgical and emergency services, some of its hospitals provide complex and advanced quaternary healthcare in various specialties, including cardiology, oncology, radiology, ophthalmology, neurosciences, paediatrics, gastroenterology, orthopaedics and critical care services. |
1 Day |
|
+1.43% |
1 Week |
|
-3.71% |
1 Month |
|
+4.76% |
3 Month |
|
+17.00% |
6 Month |
|
+37.64% |
1 Year |
|
+33.20% |
2 Year |
|
+57.78% |
5 Year |
|
+103.96% |
10 Year |
|
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 18.33 | 0.95 | 8.52 | 11.87 | 12.16 | 9.71 | 5.25 | 16.41 | 11.32 | |
Return on Capital Employed (%) | 15.42 | 7.71 | 11.45 | 10.38 | 11.01 | 11.77 | 8.97 | 15.96 | 14.36 | |
Return on Assets (%) | 6.17 | 0.18 | 1.56 | 3.91 | 4.48 | 2.95 | 1.45 | 4.98 | 3.48 |
Particulars | 9 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Shh. Funds | 1,484 | 420 | 1,875 | 2,832 | 3,214 | 3,272 | 3,372 | 3,953 | 4,448 | |
Non Curr. Liab. | 924 | 3,180 | 2,352 | 2,066 | 2,581 | 4,965 | 4,590 | 4,480 | 5,320 | |
Curr. Liab. | 1,239 | 1,967 | 2,201 | 2,224 | 2,668 | 3,722 | 3,196 | 3,559 | 4,655 | |
Minority Int. | 762 | 177 | 375 | 358 | 466 | 446 | 462 | 529 | 412 | |
Equity & Liab. | 4,409 | 5,743 | 6,804 | 7,479 | 8,928 | 12,405 | 11,620 | 12,521 | 14,836 | |
Non Curr. Assets | 2,609 | 3,237 | 4,332 | 4,610 | 5,311 | 8,310 | 7,991 | 8,425 | 9,914 | |
Curr. Assets | 1,801 | 2,506 | 2,472 | 2,869 | 3,617 | 4,096 | 3,629 | 4,096 | 4,922 | |
Misc. Exp. not W/O | ||||||||||
Total Assets | 4,409 | 5,743 | 6,804 | 7,479 | 8,928 | 12,405 | 11,620 | 12,521 | 14,836 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-06 Rs. Cr. TTM |
Net Sales | 3,876 | 5,250 | 5,931 | 6,721 | 7,963 | 8,652 | 8,608 | 10,253 | 11,933 | 12,486 | |
Other Income | 23 | 25 | 37 | 45 | 35 | 38 | 50 | 51 | 78 | 50 | |
Total Income | 3,899 | 5,275 | 5,968 | 6,767 | 7,997 | 8,690 | 8,658 | 10,304 | 12,011 | 12,536 | |
Total Expenditure | -3,358 | -4,789 | -5,582 | -6,089 | -7,074 | -7,363 | -7,506 | -8,720 | -10,307 | -10,825 | |
PBIDT | 541 | 486 | 386 | 678 | 924 | 1,327 | 1,153 | 1,584 | 1,704 | 1,711 | |
Interest | -91 | -205 | -371 | -204 | -205 | -391 | -334 | -307 | -390 | -359 | |
Depreciation | -144 | -243 | -322 | -298 | -306 | -586 | -618 | -641 | -780 | -823 | |
Taxation | -34 | -29 | -11 | -26 | -43 | -15 | -27 | -36 | -60 | -108 | |
Exceptional Items | 416 | 130 | -2 | -20 | |||||||
PAT | 272 | 9 | 98 | 279 | 368 | 315 | 174 | 601 | 475 | 421 | |
Minority Interest | -139 | -67 | 4 | -13 | -34 | -38 | -30 | -75 | -51 | -54 | |
Share Associate | 0 | -1 | 0 | 2 | 0 | 0 | 4 | -6 | |||
Other Related Items | |||||||||||
Consolidated Net Profit | 133 | -59 | 102 | 269 | 333 | 277 | 148 | 526 | 425 | 361 | |
Adjusted EPS | 3 | -1 | 3 | 5 | 7 | 6 | 3 | 11 | 9 | 7 |
Particulars | 9 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 236 | 203 | 361 | 537 | 601 | 1,223 | 1,569 | 1,314 | 1,834 | |
Cash Fr. Inv. | -448 | -786 | -1,153 | -523 | -709 | -667 | -330 | -570 | -972 | |
Cash Fr. Finan. | 203 | 578 | 654 | 46 | 134 | -675 | -1,116 | -686 | -817 | |
Net Change | -10 | -5 | -138 | 61 | 26 | -119 | 123 | 58 | 45 | |
Cash & Cash Eqvt | 248 | 253 | 131 | 192 | 225 | 115 | 235 | 299 | 365 |
Wed, 20 Sep 2023
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please be informed that the Company shall be participating in the Healthcare Forum 2023 by Kotak Securities" investors conference and shall be meeting various Investors on September 26 2023. |
Mon, 04 Sep 2023
Transcript Of The 15Th Annual General Meeting Please find enclosed herewith the transcript of the 15th Annual General Meeting of the Company held on Thursday August 31 2023.The same is also made available on the website of the Company. |
Fri, 01 Sep 2023
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report Pursuant to Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform that the 15th Annual General Meeting (AGM) of the Company was held on Thursday August 31 2023 through Video Conferencing (VC) / Other Audio-Visual Means (OAVM) and the business mentioned in the Notice convening the AGM were transacted. In this regard please find enclosed the following:1. Submission of voting results in compliance with the provisions of Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 20152. Report of Scrutinizer dated September 01 2023 in compliance with the provisions of Section 108 of the Companies Act 2013 and Rule 20(4) (Xii) of the Companies (Management and Administration) Rules 2014 |
Thu, 21 Sep 2023 |
|
|
|
|
|